亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

愈創(chuàng)藍(lán)油烴CAS#489-84-9廠家

 
 
單價(jià) 1.00 / kg對(duì)比
銷量 暫無
發(fā)貨 湖北武漢市付款后24小時(shí)內(nèi)
庫存 99000kg起訂1kg
品牌 福國醫(yī)藥
含量 99%
包裝 1-15kg
過期 長期有效
更新 2021-09-13 17:50
 

湖北福國醫(yī)藥科技有限公司

企業(yè)會(huì)員第5年
資料未認(rèn)證
保證金未繳納
  • 湖北-武漢市
  • 上次登錄 2021-09-12
  • 郭金福 (先生)   總經(jīng)理
詳細(xì)說明

愈創(chuàng)藍(lán)油烴

別名:愈創(chuàng)蘭油烴;二甲異丙奧;愈創(chuàng);愈創(chuàng)奧

英文名稱:Guaiazulenum

英文別名:Azulon;Eucazulen;KessazulenVaUmigan;AZ8;1,4-Dimethyl-7-isopropylazulene; 7-isopropyl-1,4-dimethylazulene; 1,4-dimethyl-7-(propan-2-yl)azulene

CAS489-84-9;

分子式:C15H18

分子量:198.3034

用途有抗過敏、抗炎作用。用于輻射熱灼傷、干裂、凍瘡及促進(jìn)傷口愈合等

觀:暗藍(lán)色晶體或油狀液體,有特殊氣味。易溶于液體石蠟。

質(zhì)量標(biāo)準(zhǔn):JP/CP

儲(chǔ)藏:避光,密閉,涼處保存。

 

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
甲潑尼龍琥珀酸鈉原料現(xiàn)貨供應(yīng) 烏芬那酯(氟滅酸丁酯)原料廠家 賴氨酸氯尼辛原料精品現(xiàn)貨 秋水仙堿現(xiàn)貨出廠 酒石酸托特羅定 甲氧普烯(S+ 烯蟲酯)現(xiàn)貨供應(yīng) 制霉菌素原料現(xiàn)貨直銷
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |